Formulation of Letrozole-loaded Ethyl Cellulose and Eudragit S100 Nanoparticles by Nanoprecipitation Technique and Determination of Cytotoxic Activity by MTT Assay

Q3 Medicine
A. Sailaja, Aisha Tabassum
{"title":"Formulation of Letrozole-loaded Ethyl Cellulose and Eudragit S100\nNanoparticles by Nanoprecipitation Technique and Determination of\nCytotoxic Activity by MTT Assay","authors":"A. Sailaja, Aisha Tabassum","doi":"10.2174/0124681873283442240228054238","DOIUrl":null,"url":null,"abstract":"\n\nThe major goal of this work is to develop letrozole nanoparticles using\nthe polymer precipitation technique. Formulations were prepared by using Ethyl cellulose and Eudragit\nS100 as polymers.\n\n\n\nBy varying drug-polymer ratios, a total of ten formulations were prepared. By altering\nthe drug concentration to polymer, five formulations were prepared with Ethyl cellulose and five\nwith Eudragit S100. All ten formulations were evaluated for different characterization and evaluation\nparameters such as Entrapment efficiency, Loading capacity and in vitro drug release studies,\nparticle size, stability (zeta potential), surface morphology, and drug-polymer interaction study.\n\n\n\nIn comparison, the NEC 2:1 formulation showed the smallest particle size,high stability,\ngood entrapment efficiency, and sustained drug release. This formulation was further studied to determine\nthe anticancer activity in vitro in the MCF-7 Breast cancer cell line by MTT assay. The results\nindicated that the prepared formulation exhibited anticancer activity with an IC50 value of\n91.26 micromolar.\n\n\n\nComparatively, Ethyl cellulose was proven to be a better polymer than Eudragit\nS100, and the nanoprecipitation technique was considered the most suitable technique for preparing\nletrozole nanoparticles.\n","PeriodicalId":10818,"journal":{"name":"Current Nanomedicine","volume":"40 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Nanomedicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0124681873283442240228054238","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The major goal of this work is to develop letrozole nanoparticles using the polymer precipitation technique. Formulations were prepared by using Ethyl cellulose and Eudragit S100 as polymers. By varying drug-polymer ratios, a total of ten formulations were prepared. By altering the drug concentration to polymer, five formulations were prepared with Ethyl cellulose and five with Eudragit S100. All ten formulations were evaluated for different characterization and evaluation parameters such as Entrapment efficiency, Loading capacity and in vitro drug release studies, particle size, stability (zeta potential), surface morphology, and drug-polymer interaction study. In comparison, the NEC 2:1 formulation showed the smallest particle size,high stability, good entrapment efficiency, and sustained drug release. This formulation was further studied to determine the anticancer activity in vitro in the MCF-7 Breast cancer cell line by MTT assay. The results indicated that the prepared formulation exhibited anticancer activity with an IC50 value of 91.26 micromolar. Comparatively, Ethyl cellulose was proven to be a better polymer than Eudragit S100, and the nanoprecipitation technique was considered the most suitable technique for preparing letrozole nanoparticles.
利用纳米沉淀技术制备来曲唑负载乙基纤维素和 Eudragit S100 纳米粒子并通过 MTT 检测确定其细胞毒性活性
这项工作的主要目标是利用聚合物沉淀技术开发来曲唑纳米颗粒。采用乙基纤维素和 EudragitS100 作为聚合物制备配方。通过改变药物与聚合物的浓度,用乙基纤维素制备了五种配方,用 Eudragit S100 制备了五种配方。对所有十种配方进行了不同特性和评价参数的评估,如包埋效率、装载能力和体外药物释放研究、粒度、稳定性(zeta 电位)、表面形态和药物-聚合物相互作用研究。通过 MTT 试验,进一步研究了该制剂在 MCF-7 乳腺癌细胞系中的体外抗癌活性。与 EudragitS100 相比,乙基纤维素被证明是一种更好的聚合物,而纳米沉淀技术被认为是制备莱曲唑纳米颗粒的最合适技术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Nanomedicine
Current Nanomedicine Medicine-Medicine (miscellaneous)
CiteScore
2.00
自引率
0.00%
发文量
15
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信